MMS Holdings Expert Insights Blog
Experts at MMS share their insights on trending
topics in the pharmaceutical industry.
Vivozon’s Non-Opioid Pain Killer has been granted the FDA’s Fast Track Designation through Regulatory Strategy Support from MMS
CANTON, Mich. (November 8, 2018) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that the company has successfully assisted Korea-based Vivozon Inc. in achieving a Fast Track Designation from the Food and Drug Administration (FDA) for...
Why Lay Summaries Matter and Their Future
Plain language summaries, commonly known as lay summaries, have become increasingly important for pharmaceutical companies in recent years. However, there are many sponsors that have yet to start their pilot programs for these documents. To answer some commonly-asked...
Chris Hurley Asked to Renew Three-Year Term as Americas Director of Leading Data Sciences Organization PhUSE
CANTON, Mich. (November 2, 2018) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that one of its leader’s in programming and data sciences, Chris Hurley, has been asked and has accepted a second three-year term as Americas Director of PhUSE...
Teamwork, growth, and changing lives: A conversation with Michelle Gayari
Many leaders say they value their people, but few may mean it as much as Michelle Gayari, Executive Director, Global Operations at MMS. In this candid conversation, Michelle leans in to the power of her teams and what it’s like being part of a stable, growing...
Four initiatives to combat the opioid epidemic
This article was drafted based on a presentation given at the 9th Annual Scientific Symposium presented at MMS global headquarters in Canton, Mich. Opioid use in the U.S. is widespread. Last year, there were 58 opioid prescriptions filled for every 100 U.S. citizens,...
MMS Submission Support for Paratek Pharmaceuticals Garners FDA Approval
MMS Submission Support for Paratek Pharmaceuticals Garners FDA Approval and Successful MAA Filing of NUZYRA™ (Omadacycline)CANTON, Mich. (October 11, 2018) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today their expert support to...
Detroit-Area Life Sciences Firm Pledges More Than $250,000 in Employee Hours to Local Volunteer Initiatives
CANTON, Mich. (October 5, 2018) – MMS Holdings Inc. (MMS) – award-winning, data-focused CRO – announced today its renewed dedication to the local communities surrounding Detroit and Ann Arbor by allocating a substantial amount of colleague time to volunteer...
Behind-the-Scenes: Staying in Front of Pharmaceutical Industry Regulations
Regulations in the pharmaceutical and biotech industry are constantly evolving. Staying informed of all updates and navigating changes internally is a monumental task. To learn how MMS experts traverse these waters, we connect with Amanda Beaster, Ph.D., Technical...
Business, Relationships, and Vision: A conversation with Uma Sharma, Ph.D.
Questions arise from time to time about the origins of MMS, its philosophy, and the beliefs of its leaders. In this blog article, Chief Scientific Officer (CSO), Dr. Uma Sharma discusses how she started MMS in 2006 and how it’s become the award-winning, global...